{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:37:09Z","timestamp":1763037429906,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10143-020-01250-1","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T13:03:03Z","timestamp":1581685383000},"page":"579-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety aspects of opioid-na\u00efve patients with high-grade glioma treated with D,L-Methadone: an observational case series"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4912-2917","authenticated-orcid":false,"given":"Christian","family":"von der Brelie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bawarjan","family":"Schatlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chistoph","family":"Bettag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veit","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"1250_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41698-018-0070-1","volume":"2","author":"M Abedalthagafi","year":"2018","unstructured":"Abedalthagafi M, Barakeh D, Foshay KM (2018) Immunogenetics of glioblastoma: the future of personalized patient management. NPJ Precis Oncol 2:27. https:\/\/doi.org\/10.1038\/s41698-018-0070-1","journal-title":"NPJ Precis Oncol"},{"key":"1250_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"1250_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3171\/2016.7.JNS16396","volume":"127","author":"M Rahman","year":"2017","unstructured":"Rahman M, Abbatematteo J, De Leo EK, Kubilis PS, Vaziri S, Bova F, Sayour E, Mitchell D, Quinones-Hinojosa A (2017) The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma. J Neurosurg 127:123\u2013131. https:\/\/doi.org\/10.3171\/2016.7.JNS16396","journal-title":"J Neurosurg"},{"key":"1250_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H-J, ALA-Glioma Study Group (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392\u2013401. https:\/\/doi.org\/10.1016\/S1470-2045(06)70665-9","journal-title":"Lancet Oncol"},{"key":"1250_CR5","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu J-J, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z (2015) Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma. JAMA 314:2535\u20132543. https:\/\/doi.org\/10.1001\/jama.2015.16669","journal-title":"JAMA"},{"key":"1250_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/pon.4581","volume":"27","author":"AJ Applebaum","year":"2018","unstructured":"Applebaum AJ, Buda K, Kryza-Lacombe M, Buthorn JJ, Walker R, Shaffer KM, D\u2019Agostino TA, Diamond EL (2018) Prognostic awareness and communication preferences among caregivers of patients with malignant glioma. Psychooncology 27:817\u2013823. https:\/\/doi.org\/10.1002\/pon.4581","journal-title":"Psychooncology"},{"key":"1250_CR7","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1158\/0008-5472.CAN-08-1227","volume":"68","author":"C Friesen","year":"2008","unstructured":"Friesen C, Roscher M, Alt A, Miltner E (2008) Methadone, commonly used as maintenance medication for outpatient treatment of opioid dependence, kills leukemia cells and overcomes Chemoresistance. Cancer Res 68:6059\u20136064. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1227","journal-title":"Cancer Res"},{"key":"1250_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.4161\/cc.28493","volume":"13","author":"C Friesen","year":"2014","unstructured":"Friesen C, Hormann I, Roscher M, Fichtner I, Alt A, Hilger R, Debatin K-M, Miltner E (2014) Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma. Cell Cycle 13:1560\u20131570. https:\/\/doi.org\/10.4161\/cc.28493","journal-title":"Cell Cycle"},{"key":"1250_CR9","unstructured":"Wick W (2015) Gliomtherapie mit Methadon"},{"key":"1250_CR10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.21873\/anticanres.11438","volume":"37","author":"J Onken","year":"2017","unstructured":"Onken J, Friesen C, Vajkoczy P, Misch M (2017) Safety and tolerance of D,L-methadone in combination with chemotherapy in patients with glioma. Anticancer Res 37:1227\u20131236. https:\/\/doi.org\/10.21873\/anticanres.11438","journal-title":"Anticancer Res"},{"key":"1250_CR11","unstructured":"Gesch CB, Prof V, Hallek M, Dgho V, Prof B, Prof V, Wei F, Alexanderplatz V, Tel B (2017) Stellungnahme der DGHO Methadon bei Krebspatienten: Zweifel an Wirksamkeit und Sicherheit. 1\u20133"},{"key":"1250_CR12","unstructured":"Palliativmedizin DG f (2017) Stellungnahme der Deutschen Gesellschaft f\u00fcr Palliativmedizin zum Einsatz von D,L-Methadon zur Tumortherapie (Stand: 5.7.2017)"},{"key":"1250_CR13","unstructured":"Cancer Institute N (2017) Common terminology criteria for adverse events (CTCAE) common terminology criteria for adverse events (CTCAE) v5.0"},{"key":"1250_CR14","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00280-019-03816-3","volume":"83","author":"H Oppermann","year":"2019","unstructured":"Oppermann H, Matusova M, Glasow A, Dietterle J, Baran-Schmidt R, Neumann K, Meixensberger J, Gaunitz F (2019) D,L-Methadone does not improve radio- and chemotherapy in glioblastoma in vitro. Cancer Chemother Pharmacol 83:1017\u20131024. https:\/\/doi.org\/10.1007\/s00280-019-03816-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"1250_CR15","doi-asserted-by":"publisher","first-page":"iii285","DOI":"10.1093\/neuonc\/noy139.264","volume":"20","author":"P Latzer","year":"2018","unstructured":"Latzer P, Kessler T, Sahm F, R\u00fcbmann P, Hielscher T, Platten M (2018) P04.30 methadone does not increase toxicity of temozolomide in glioblastoma cells. Neuro Oncol 20:iii285\u2013iii285. https:\/\/doi.org\/10.1093\/neuonc\/noy139.264","journal-title":"Neuro Oncol"},{"key":"1250_CR16","doi-asserted-by":"publisher","first-page":"CNS18","DOI":"10.2217\/cns-2018-0006","volume":"7","author":"K Brawanski","year":"2018","unstructured":"Brawanski K, Brockhoff G, Hau P, Vollmann-Zwerenz A, Freyschlag C, Lohmeier A, Riemenschneider MJ, Thom\u00e9 C, Brawanski A, Proescholdt MA (2018) Efficacy of D,L-methadone in the treatment of glioblastoma in vitro. CNS Oncol 7:CNS18. https:\/\/doi.org\/10.2217\/cns-2018-0006","journal-title":"CNS Oncol"},{"key":"1250_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00066-013-0392-4","volume":"189","author":"J H\u00fcbner","year":"2013","unstructured":"H\u00fcbner J, Muenstedt K, Muecke R, Micke O, Stoll C, Kleeberg UR, Buentzel J, Dennert G, Prott FJ, PRIO (Working group Prevention and Integrative Oncology of the German Cancer Society), AKTE (Working group Trace Elements of the German Society of Radiooncology (DEGRO)) (2013) Counseling cancer patients on complementary and alternative medicine. Strahlentherapie und Onkol 189:613\u2013617. https:\/\/doi.org\/10.1007\/s00066-013-0392-4","journal-title":"Strahlentherapie und Onkol"},{"key":"1250_CR18","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1055\/s-0041-100585","volume":"140","author":"I Rudolph","year":"2015","unstructured":"Rudolph I, Seilacher E, K\u00f6ster M-J, Stellamanns J, Liebl P, Zell J, Ludwig S, Beck V, H\u00fcbner J (2015) Der Informationsbedarf von Patienten mit Krebserkrankungen in Deutschland \u2013 eine Befragung von Patienten und Angeh\u00f6rigen. DMW - Dtsch Medizinische Wochenschrift 140:e43\u2013e47. https:\/\/doi.org\/10.1055\/s-0041-100585","journal-title":"DMW - Dtsch Medizinische Wochenschrift"},{"key":"1250_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/gut.2004.055251","volume":"54","author":"T Piche","year":"2005","unstructured":"Piche T, Vanbiervliet G, Cherikh F, Antoun Z, Huet PM, Gelsi E, Demarquay JF, Caroli-Bosc FX, Benzaken S, Rigault MC, Renou C, Rampal P, Tran A (2005) Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study. Gut 54:1169\u20131173. https:\/\/doi.org\/10.1136\/gut.2004.055251","journal-title":"Gut"},{"key":"1250_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2165\/11599780-000000000-00000","volume":"26","author":"J Piedad","year":"2012","unstructured":"Piedad J, Rickards H, Besag FMC, Cavanna AE (2012) Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations. CNS Drugs 26:319\u2013335","journal-title":"CNS Drugs"},{"key":"1250_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11060-018-2962-x","volume":"140","author":"M Sacher","year":"2018","unstructured":"Sacher M, Meixensberger J, Krupp W (2018) Interaction of quality of life, mood and depression of patients and their informal caregivers after surgical treatment of high-grade glioma: a prospective study. J Neuro-Oncol 140:367\u2013375. https:\/\/doi.org\/10.1007\/s11060-018-2962-x","journal-title":"J Neuro-Oncol"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-020-01250-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10143-020-01250-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-020-01250-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T21:26:43Z","timestamp":1613251603000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10143-020-01250-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1250"],"URL":"https:\/\/doi.org\/10.1007\/s10143-020-01250-1","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"type":"print","value":"0344-5607"},{"type":"electronic","value":"1437-2320"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"15 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was not funded. The authors declare that they have no conflict of interest. This study was approved by the institutional review board, ethical approval was obtained. Informed consent was not achieved since this was a retrospective observational study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}